| Previous Section | Index | Home Page |
12 Dec 2006 : Column 1023W—continued
Repeat application
Excluded item(s)
Existing debt, for budgeting and crisis loans combined, too high
Applicant excluded by direction
Source:
PBMIS. (PBMIS data are not available for 1996-97, so the Secretary of State’s annual report on the Social Fund has been used instead.)
Social Security Benefits: West Chelmsford
Mr. Burns: To ask the Secretary of State for Work and Pensions how many households in West Chelmsford constituency were in receipt of (a) housing benefit and (b) council tax benefit in each year since 1996; and how many of the recipients were (i) pensioners and (ii) non-pensioner households. [108105]
Mr. Plaskitt: The information is not available, as these figures are not produced below local authority area.
Mr. Burns: To ask the Secretary of State for Work and Pensions how many people in West Chelmsford constituency were in receipt of incapacity benefit in each year since 1996. [108106]
Mrs. McGuire: The information is in the following table.
| Incapacity benefit and severe disablement allowance claimants in the West Chelmsford constituency | |
| Number | |
| Notes: 1. The parliamentary constituency figures for the years 1996 to 1999 have been produced using the 5 per cent. data and have been rated up proportionally using the Great Britain WPLS 100 per cent. IB/SDA totals. 2. From 1996 to 1999, figures are rounded to the nearest hundred. From 2000 onwards figures are rounded to the nearest 10. 3. “Claimant” figures include all IB and SDA (including IB credits only cases). Source: DWP Information Directorate, 5 per cent. Samples from 1996 to 1999 and Work and Pensions Longitudinal Study 100 per cent. data thereafter. | |
State Retirement Pensions: Overseas Residence
Mr. Andrew Turner: To ask the Secretary of State for Work and Pensions how many people overseas receive the state retirement pension; and of those how many receive (a) 100 per cent., (b) up to 20 per cent., (c) 21 to 40 per cent., (d) 41 to 60 per cent., (e) 61 to 80 per cent. and (f) over 80 per cent. of the UK entitlement. [108753]
James Purnell: Information that is available is in the following table:
The total number of overseas customers in receipt of state pension in September 2006 was 1,075,860.
| Entitlement (as a percentage) to the basic state pension | Number of customers as at September 2006 |
Winter Fuel Payments
Mr. Byers: To ask the Secretary of State for Work and Pensions if he will bring forward proposals to start the payment of the £100 winter fuel allowance on an individual’s 80th birthday. [108773]
James Purnell: People aged 80 or over in the winter fuel payment qualifying week—the third full week in September—qualify for the extra £100 in their winter fuel payment. We use this date in order to establish entitlement and make payments before Christmas in time for the winter bills. We have no plans to change these arrangements.
Greg Mulholland: To ask the Secretary of State for Work and Pensions what estimate he has made of the cost of extending the eligibility for winter fuel payments received by those over 60 to (a) those in receipt of the higher or middle rate of disability living allowance care component, (b) those in receipt of the support component of the employment and support allowance and (c) those receiving the severe disability premium or enhanced disability premium. [108259]
James Purnell: The estimated annual cost of extending the eligibility to winter fuel payments to people aged under 60 in receipt of the higher or middle rate care component of disability living allowance is £210 million. To extend the payments to people aged under 60 in receipt of the severe disability premium or the enhanced disability premium the estimated cost is £70 million. We cannot give an estimate for extending the payments to those who will receive the support component of ESA when it is introduced in 2008 as we are still developing the eligibility criteria and cannot currently estimate the number of people likely to receive this component.
Notes:
1. Figures rounded to the nearest ten million.
2. Figures are for 2006-07.
3. Costs have been calculated using the DWP Budget 2006 forecast.
Workers' Compensation
Jon Cruddas: To ask the Secretary of State for Work and Pensions how much has been paid by the Government to claimants under the Pneumoconiosis Etc. (Workers’ Compensation) Act 1979 (a) in the UK, (b) in the London Borough of Barking and Dagenham and (c) in Dagenham constituency; and what proportion of these payments was clawed back from insurers by the Government. [104731]
Mr. Jim Murphy: A total of £173,654,332 has been paid to date under the Pneumoconiosis Etc. (Worker’s Compensation) Act 1979. Information is not available below national level. No recovery (claw back) is made from insurers in respect of payments made under this Act.
Health
A and E Departments
Julia Goldsworthy: To ask the Secretary of State for Health what percentage of accident and emergency patients in England had a trolley wait of over four hours in the last period for which figures are available. [102007]
Ms Rosie Winterton: Information on the percentage of patients not placed in a bed in a ward within four hours of a decision to admit, commonly referred to as a ‘trolley wait’, is reported by national health service trusts quarterly. During the period July to September 2006 there were 4,892,547 attendances at all types of accident and emergency department, of which 752,049 were subsequently admitted.
Of those admitted patients, it was reported that 1.4 per cent. were not placed in a bed in a ward within four hours of a decision to admit being made.
Adhesive Arachnoiditis
Mrs. Humble: To ask the Secretary of State for Health if she will include adhesive arachnoiditis on the NHS list and codification of medical conditions. [104270]
Caroline Flint: National health service (NHS) standards for the coding of medical conditions include terminologies, for example the read codes and SNOMED clinical terms which support point of care recording in an electronic health record, and statistical classifications which support business requirements and epidemiology. The former consequently often provide more specific differentiation than the latter.
Within SNOMED clinical terms, in respect of whose establishment as an international classification the NHS in England has led the world, adhesive arachnoiditis can be distinctly represented, and all versions of the read codes support a representation of arachnoiditis.
With regard to classifications, the mandatory recording and reporting of diagnostic information for an episode of admitted patient care in the NHS in England is determined by the World Health Organisation's International Statistical Classification of Disease and Related Health Problems—Tenth Revision (ICD-10). Adhesive arachnoiditis is accommodated within ICD-10 classification codes, but there is no mechanism for distinguishing “adhesive arachnoiditis” from other forms of “arachnoiditis”.
Adverse Drug Reactions
Mr. Lansley: To ask the Secretary of State for Health what proportion of in-patients' hospital stays were prolonged by adverse drug reactions in the last 12 months; what her latest estimate is of the proportion of hospital admissions due to adverse drug reactions; and if she will make a statement. [107385]
Andy Burnham: The Department does not centrally hold information about the proportion of in-patients who had their hospital stay prolonged by adverse drug reactions. During 2004-05, there were 68,389 finished consultant episodes (FCE) where adverse drug reactions were identified as a secondary diagnosis in hospitals in England.
A finished consultant episode (FCE) is defined as a period of admitted patient care under one consultant within one health care provider. These figures do not represent the number of patients, as an individual may have more than one episode of care within the year. The secondary diagnosis shows diagnoses relevant to
the episode of case but will not have been recorded as the main reason for admission. It is also not possible to say whether the drugs were prescribed and administered in hospital or in primary care.
Agency Staff
Mr. Stewart Jackson: To ask the Secretary of State for Health how much was spent on temporary (a) medical and (b) non-medical agency staff in each trust area within the East of England Strategic Health Authority area in the last period for which figures are available; and if she will make a statement. [105259]
Ms Rosie Winterton: Information is not available in the format requested.
Alcohol Misuse
Susan Kramer: To ask the Secretary of State for Health what auditing procedures are in place to monitor spending on treatment for alcohol misuse by individual primary care trusts. [104157]
Caroline Flint: The Department, guided by the National Audit Office, is currently developing a framework to enable a regular assessment of the level of spend locally on alcohol interventions and treatment. Expenditure on alcohol treatment is subject to the same audit requirements as all other national health service expenditure.
Alzheimer's Disease
Mr. Marsden: To ask the Secretary of State for Health if she will publish the economic model used by the National Institute for Health and Clinical Excellence in its most recent appraisal of drugs for Alzheimer's disease. [108755]
Andy Burnham: The economic model used by the National Institute for Health and Clinical Excellence (NICE) in the development of its appraisal of drugs for Alzheimer's disease was produced for NICE by the university of Southampton. The economic model is protected by intellectual property rights and contains commercial-in-confidence information. The university is protected by the terms of the contract by which it undertakes this work.
Asylum Seekers
Mr. David Hamilton: To ask the Secretary of State for Health what medical checks are made on asylum applicants to the UK. [106857]
Caroline Flint: Asylum seekers can receive medical checks in the normal way when they register with GP practices. In England, Department funded health assessments including TB screening can also generally be accessed where initial accommodation for asylum seekers is located. Immigration officers should also refer any entrant claiming asylum at a point of entry to the United Kingdom for a medical examination under the Immigration Act. Asylum claims are determined in accordance with the 1951 UN Convention on the Status of Refugees and its Protocol. They are not based on the applicant's state of health.
Biologics
Graham Stringer: To ask the Secretary of State for Health what the total cost has been of biologics by acute trusts within (a) Manchester, (b) Greater Manchester, (c) the North West region and (d) England since it was made available; and how many prescriptions for biologics were dispensed in each area. [108548]
Andy Burnham: The information requested can be provided only at disproportionate cost.
Bowel Cancer Screening
Mr. Hunt: To ask the Secretary of State for Health what the average cost was of establishing a National Bowel Cancer Screening Programme hub; and what the annual running costs of each hub were in each year since their introduction. [108516]
Ms Rosie Winterton: The average cost of setting up a programme hub is £250,000. When fully operational, each hub will serve a population of around 10 million people. Each test costs 48p per head of primary care trust population, so the average annual running costs of each hub will be £4.8 million.
Within the NHS Bowel Cancer Screening Programme, five programme hubs across England will invite men and women to participate in screening, send out the faecal occult blood (FOB) testing kits, analyse the returned kits and send results out. 90 to 100 local screening centres will provide endoscopy services for the 2 per cent. of men and women who have a positive FOB test result.
The five hubs have been confirmed as Rugby (West Midlands and the North West—began operations in July 2006), Guildford (Southern—began operations in September 2006), St. Marks (London—began operations in October 2006), Gateshead (North East) and Nottingham (Eastern). All five hubs will be operational by March 2007.
Cancer Treatment
Mr. Andrew Turner: To ask the Secretary of State for Health what estimate she has made of the number of lives which have been saved as a result of new cancer treatments made available in the last five years; and what information she uses to determine such an estimate. [108751]
Ms Rosie Winterton: We have not estimated the number of lives saved as a result of new cancer treatments.
However, we have estimated that between 1996 and 2004, cancer mortality in people under 75 fell by nearly 16 per cent. which equates to over 50,000 lives saved over this period.
‘Lives Saved’ is an assessment of the cumulative effect of year-on-year reductions to the numbers of deaths in a specific age group and from a specific cause of death. It is not the measurement of the effect of a particular course or courses of treatment on mortality rates.
| Next Section | Index | Home Page |